Drawing for CUVUE

USPTO serial 79359922

CUVUE

Reviewed by CopyMark Law Group

Reg. 7318381Status 700Registered
Filing date
Status date
Registration date
Mar 5, 2024
Examiner
KETCHUM, BRENDAN J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CUVUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Heather Smith-Carra

Heather Smith-Carra Banner & Witcoff, Ltd.1100 13th Street NWSuite 1200Washington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical products in the nature of medicines for the treatment of Wilson's disease; chemical preparations for the treatment of Wilson's disease for medical use; chemical preparations for the treatment of Wilson's disease for pharmaceutical use; medicinal substances for the treatment of Wilson's disease; medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products in the nature of medicines and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson's disease; pharmaceutical and chemical preparations for measuring copper levels; chemical reagents for medical use, namely, for the diagnosis of Wilson's disease; chemical reagents for diagnostic use in patients suffering from Wilson's disease; pre-filled syringes sold filled with medicine for the treatment of Wilson's disease for medical use; medicated serums for diagnostic use for the diagnosis of Wilson's disease; biological preparations in the nature of medicines for medical use for measuring copper in patients suffering from Wilson's disease; chemical preparations in the nature of medicines for medical use for measuring copper in patients suffering from Wilson's disease; clinical diagnostic reagents; diagnostic preparations in the nature of medicines for medical use for the treatment of Wilson's disease; medical diagnostic reagents and assays for analyzing body fluids to diagnose the level of copperACTIVE—
044Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for diagnosing the level of copper in patients suffering from Wilson's disease; medical screening; health care for patients suffering from Wilson's disease; health assessment services for patients suffering from Wilson's disease; home-visit nursing care; blood analysis services provided by medical laboratories for patients suffering from Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients suffering from Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients suffering from Wilson's disease; medical diagnostic testing, monitoring and reporting services for patients suffering from Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 5, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 5, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 19, 2023GPNXNOTIFICATION PROCESSED BY IB—
Dec 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 29, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 8, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 18, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2023RFNTREFUSAL PROCESSED BY IB—
Jun 9, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2023RFRRREFUSAL PROCESSED BY MPU—
Apr 26, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 25, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2023DOCKASSIGNED TO EXAMINER—
Jan 13, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 9, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance